usdept depart health human servic usdept usbureau food drug administr usbureau advisori committe notic meet agenc agenc food drug administr hh agenc action action notic action summari summari notic announc forthcom meet public advisori committe food drug administr fda notic also summar procedur meet method interest person may particip open public hear fda advisori committe meet follow advisori committe meet announc dermatolog drug advisori committe date time place februari 16 1994 8 confer rm g j parklawn bldg 5600 fisher lane rockvil md type meet contact person open public hear 8 9 unless public particip last long open committe discuss 9 12 ermona b mcgoodwin valeri meali center drug evalu research hfd9 food drug administr 5600 fisher lane rockvil md 20857 3014435455 gener function committe committe review evalu data safeti effect market investig human drug use treatment dermatolog diseas agenda_open public hear interest person may present data inform view oral write issu pend committe desir make formal present notifi contact person februari 11 1994 submit brief statement gener natur evid argument wish present name address propos particip indic approxim time requir make comment open committe discuss committe discuss new drug applic nda 19821 soriatan reg acitretin roch dermatolog treatment psoriasi joint meet dermatolog drug nonprescript drug advisori committe date time place februari 16 1994 1 p confer rm g j parklawn bldg 5600 fisher lane rockvil md type meet contact person open public hear 1 p 2 p unless public particip last long open committe discuss 2 p 5 p ermona b mcgoodwin lee l zwanzig center drug evalu research hfd9 food drug administr 5600 fisher lane rockvil md 20857 3014435455 gener function committe dermatolog drug advisori committe review evalu data safeti effect market investig human drug use treatment dermatolog diseas nonprescript drug advisori committe review evalu avail data concern safeti effect counter nonprescript human drug product use treatment broad spectrum human symptom diseas agenda_open public hear interest person may present data inform view oral write issu pend committe desir make formal present notifi contact person februari 11 1994 submit brief statement gener natur evid argument wish present name address propos particip indic approxim time requir make comment open committe discuss committe discuss new drug applic nda 20310 ketoconazol 1 shampoo johnson johnson consum product treatment dandruff nation mammographi qualiti assur advisori committe date time place februari 17 18 1994 8 30 ballroom holiday inn metro center 775 12th st nw washington dc type meet contact person open public hear februari 17 1994 8 30 9 30 unless public particip last long open committe discuss 9 30 5 p open committe discuss februari 18 1994 8 30 5 p charl k showalt center devic radiolog health hfz240 food drug administr 1901 chapman ave rockvil md 20857 3015943311 gener function committe committe advis develop appropri qualiti standard regul mammographi facil agenda_open public hear interest person may present data inform view oral write issu pend committe desir make formal present notifi contact person januari 31 1994 submit brief statement gener natur evid argument wish present name address propos particip indic approxim time requir make comment open committe discuss committe 1 discuss interim final standard accredit bodi facil 2 receiv statu report fda activ relat implement mammographi qualiti standard act 1992 pub l 102539 3 discuss prioriti futur standard board tea expert date time place februari 24 25 1994 10 new york region laboratori rm 700 850 third ave brooklyn ny type meet contact person open public hear februari 24 1994 10 11 unless public particip last long open committe discuss 11 4 30 p open committe discuss februari 25 1994 10 4 30 p robert h dick new york region laboratori food drug administr 850 third ave brooklyn ny 11232 7189655730 gener function committe committe advis establish uniform standard puriti qualiti fit consumpt tea import unit state 21 u c 42 agenda_open public hear interest person may present data inform view oral write issu pend committe open committe discuss committe discuss select tea standard fda public advisori committe meet may mani four separ portion 1 open public hear 2 open committe discuss 3 close present data 4 close committe deliber everi advisori committe meet shall open public hear portion whether also includ three portion depend upon specif meet involv close portion meet announc notic date time reserv open portion committe meet list open public hear portion meet shall least 1 hour long unless public particip last long emphas howev 1 hour time limit open public hear repres minimum rather maximum time public particip open public hear may last whatev longer period committe chairperson determin facilit committe work public hear subject fda guidelin subpart c 21 cfr part 10 concern polici procedur electron media coverag fda public administr proceed includ hear public advisori committe 21 cfr part 14 21 cfr 10 205 repres electron media may permit subject certain limit videotap film otherwis record fda public administr proceed includ present particip meet advisori committe shall conduct insofar practic accord agenda publish feder regist notic chang agenda announc begin open portion meet interest person wish assur right make oral present open public hear portion meet shall inform contact person list either oral write prior meet person attend hear advanc meet request opportun speak allow make oral present hear conclus time permit chairperson discret agenda question address committe current list committe member avail meet locat day meet transcript open portion meet may request write freedom inform offic hfi35 food drug administr rm 12a16 5600 fisher lane rockvil md 20857 approxim 15 work day meet cost 10 cent per page transcript may view docket manag branch hfa305 food drug administr rm 123 12420 parklawn dr rockvil md 20857 approxim 15 work day meet hour 9 4 p monday friday summari minut open portion meet may request write freedom inform offic address begin approxim 90 day meet notic issu section 10 1 2 feder advisori committe act 5 u c app 2 fda regul 21 cfr part 14 advisori committe date januari 21 1994 summari signer jane e henney signer signjob deputi commission oper signjob frfile fr doc 941702 file 12694 8 45 frfile bill bill code 416001f bill